Pomohaibo V. M., Berezan O. I., Petrushov A. V.


About the author:

Pomohaibo V. M., Berezan O. I., Petrushov A. V.



Type of article:

Scentific article


More than 80% of genome genes are involved in development of the human brain that is much greater than the need for the formation of any other organ in human body. Mutations of one or more of these genes may cause brain damage and mental diseases. One of these diseases is bipolar disorder, or manic-depressive psychosis – serious and widespread mental disorder. Currently its global frequency varies from 0.4% to 1.3% according to different sources. The ratio between women and men is 5:4. Bipolar disorder is a disease with hereditary predisposition. The coefficient of heritability as a fate of the genetic component of the disease is about 46%. Thus, the impact of environmental conditions on risk of the disorder developing reaches 54% that indicates a possibility of successful treatment of some of its forms. The bipolar and related disorders occupy an intermediate position between schizophrenia and other depressive and psychotic diseases. Due to these features, its diagnosis is quite complex and approximate. To study the genetics of bipolar disorder there are used genealogical methods (family, twin, and adoption studies), linkage studies, a search of candidate genes, genome-wide association studies its. Genome-wide association studies and meta-analysis of experimental data are most effective research technology. Making use of this technology, 5 genes (ANK3, CACNA1C, ODZ4, TRANK1, ADCY2), whose mutations are directly involved in the risk of developing the disease, have been identified at this time in large combined samples of patients with bipolar disorder and controls. The ANK3 gene (10q21) encodes the ankyrin G protein, which is involved in formation of an initial axon segment. The CACNA1C gene (12p13.3) encodes a protein that is part of the calcium ion channels. The ODZ4 gene ((11q14.1)) encodes a protein that is involved in the development of neurons and axonal myelinization. The TRANK1 gene (3p22.2) encodes a protein that is sensitive to propylvaleric acid. The ADCY2 gene (5p15.31) encodes the membrane adenylate cyclase enzyme, which plays a key role in the pathway of receptors of a number of neurotransmitters. There are also 9 genes that are expressed in the dorsolateral zone of the prefrontal cortex of patients with bipolar disorder and 6 functional pathways that can cause susceptibility to disorder, namely, signaling pathways of glutamate, corticotropic hormone, endothelin 1, phospholipase C, β-adrenaline receptors and myocardial hypertrophy. These data can play a key role in determining the direction of pathophysiological research to develop effective methods for treatment of bipolar disorder. In addition, single-nucleotide polymorphisms have been identified in 3 circadian genes (NF1A, CRY2, NPAS2) that affect the daily rhythm of changing episodes of the disease. The product of the NF1A gene (1p31.3) is involved in the DNA transcription and replication. The CRY2 gene (11p11.2) expresses in all body tissues and encodes cryptocchrome-2 protein, which is involved in regulating the functions of light-dependent proteins and preserving daily rhythmicity. The NPAS2 gene (2q11.2) encodes a protein that is involved in providing feedback between neurons. There is shown that single-nucleotide polymorphism rs6738097 in the NPAS2 gene can be used as a biomarker of bipolar disorder dependent on disruption of the daily rhythm.


bipolar disorder, genealogical method, clutch group, candidate gene, general genetic association, meta-analysis, functional pathway, circadian gene, single nucleotide polymorphism


  1. Kang HJ, Kawasawa YI, Cheng F, Zhu Y, Xu X, Li M, et al. Spatio-temporal transcriptome of the human brain. Nature. 2011 Oct 26;478(7370): 483-9.
  2. Pomohaibo VM, Berezan OI, Petrushov AV. Henetyka rozladiv autystychnoho spektru. Svit medytsyny ta biolohii. 2017;1(59):208-12. [in Ukrainian].
  3. Pomohaibo VM, Berezan OI, Petrushov AV. Henetyka spetsyfichnoho rozladu navchannia. Psykholohiia i osobystist. 2018;2(14):197-207. [in Ukrainian].
  4. Pomohaibo VM, Berezan OI, Petrushov AV. Henetyka syndromu defitsytu uvahy z hiperaktyvnistiu. Psykholohiia i osobystist. 2018;1(13):17182. [in Ukrainian].
  5. Diagnostic and statistical manual of mental disorders: DSM-5. 5th ed. Washington, DC: American Psychiatric Association; 2013. 992 p.
  6. Ferrari AJ, Stockings E, Khoo JP, Erskine HE, Degenhardt L, Vos T, et al. The prevalence and burden of bipolar disorder: findings from the Global Burden of Disease Study 2013. Bipolar Disorders. 2016;18(5):440-50.
  7. Kerner B. Genetics of bipolar disorder. The Application of Clinical Genetics. 2014 Febr;7:33-42. 8.
  8. Mahon K, Burdick KE, Malhotra AK. Heritability of Bipolar Disorder. In: Bipolar disorder in youth. Eds. Strakowski SM, DelBello MP, Adler CM. NY: Oxford University Press; 2015. 402 p.: 94-108.
  9. Emiroglu FNI, Diler RS. Pediatric bipolar disorders: from the perspective of Turkey. J Can Acad Child Adolesc Psychiatry. 2009;18(3):206-14.
  10. Geller B, Tillman R, Bolhofner K, Zimerman B, Strauss NA, Kaufmann P. Controlled, blindly rated, direct interview family study of a prepubertal and early adolescent bipolar I disorder phenotype: morbid risk, age at onset, and comorbidity. Arch Gen Psychiatry. 2006;63(10):1130-8.
  11. Faraone SV, Glatt SJ, Tsuang MT. The genetics of pediatric-onset bipolar disorder. Biol. Psychiatry. 2003;53(11):970-7.
  12. Kassem L, Lopez V, Hedeker D, Steele J, Zandi P. Bipolar Disorder Consortium NIMH Genetics Initiative, et al. Familiality of polarity at illness onset in bipolar affective disorder. Am J Psychiatry. 2006 Oct;163(10):1754-9.
  13. Fisfalen ME, Schulze TG, DePaulo JR Jr, DeGroot LJ, Badner JA, McMahon FJ. Familial variation in episode frequency in bipolar affective disorder. Am J Psychiatry. 2005;162(7):1266-72.
  14. Saunders EH, Scott LJ, McInnis MG, Burmeister M. Familiality and diagnostic patterns of subphenotypes in the National Institutes of Mental Health bipolar sample. Am J Med Genet B Neuropsychiatr. Genet. 2008;147B(1):18-26.
  15. Kieseppä T, Partonen T, Haukka J, Kaprio J, Lönnqvist J. High concordance of bipolar I disorder in a nationwide sample of twins. Am J Psychiatry. 2004 Oct;161(10):1814-21.
  16. McQueen MB, Devlin B, Faraone SV, Nimgaonkar VL, Sklar P, Smoller JW, et al. Combined analysis from eleven linkage studies of bipolar disorder provides strong evidence of susceptibility loci on chromosomes 6q and 8q. Am J Hum Genet. 2005;77:582-95.
  17. Craddock N, Sklar P. Genetics of bipolar disorder: successful start to a long journey. Trends Genet. 2009;25(2):99-105.
  18. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 2007 Jun 7;447(7145):661-78.
  19. Baum AE, Akula N, Cabanero M, Cardona I, Corona W, Klemens B, et al. A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder. Mol Psychiatry. 2008;13(2):197-207.
  20. Ferreira MA, O’Donovan MC, Meng YA, Jones IR, Ruderfer DM, Jones L, et al. Collaborative genomewide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nature Genetics. 2008;40(9):1056-8.
  21. Human Gene Database [Internet]. 2017 [cited 2018 Jan 10]. Available from: http://www.genecards.org; http://www.malacards.org
  22. Shinozaki G, Potash JB. New developments in the genetics of bipolar disorder. Curr Psychiatry Rep. 2014 Nov;16(11):493.
  23. Psychiatric GWAS Consortium Bipolar Disorder Working Group. Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. Nat Genet. 2011 Sep 18;43(10):977-83.
  24. Chen DT, Jiang X, Akula N, Shugart YY, Wendland JR, Steele CJM, et al. Genome-wide association study meta-analysis of European and Asianancestry samples identifies three novel loci associated with bipolar disorder. Mol Psychiatry. 2013;18(2):195-205.
  25. Mühleisen TW, Leber M, Schulze TG, Strohmaier J, Degenhardt F, Treutlein J, et al. Genome-wide association study reveals two new risk loci for bipolar disorder. Nat Commun. 2014 Mar 11;5:3339.
  26. Nurnberger JI Jr, Koller DL, Jung J, Edenberg HJ, Foroud T, Guella I, et al. Identification of pathways for bipolar disorder: a meta-analysis. JAMA Psychiatry. 2014;71(6):657-64.
  27. Lee HJ, Woo HG, Greenwood TA, Kripke DF, Kelsoe JR. A genome-wide association study of seasonal pattern mania identifies NF1A as a possible susceptibility gene for bipolar disorder. J Affect Disord. 2013;145(2):200-7.
  28. Geoffroy PA, Lajnef M, Bellivier F, Jamain S, Gard S, Kahn JP, et al. Genetic association study of circadian genes with seasonal pattern in bipolar disorders. Sci. Rep. 2015;5(Art, 10232). 8 p.

Publication of the article:

«Bulletin of problems biology and medicine» Issue 4 Part 2 (147), 2018 year, 62-65 pages, index UDK 616.89